Comorbidities: A Decider of Severe Clinical Outcomes in COVID-19 Patients

被引:0
作者
Agrawal, Rahul [1 ]
机构
[1] Datta Meghe Inst Med Sci Deemed Univ, Dept Community Med, Jawaharlal Nehru Med Coll, Wardha 442001, Maharashtra, India
关键词
COVID-19; diabetes; CVD; COPD; comorbidity; obesity; hypertension; renal ailments; DIABETES-MELLITUS; RISK-FACTORS;
D O I
10.9734/JPRI/2021/v33i39A32133
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Comorbidity is the biggest decider in COVID-19 pandemic whether the infected person will develop the severe clinical outcome or not. It is one of the few conclusions that has widespread acceptance. Summary:After analyzing the case fatalities of COVID-19, many patients were found to be having either one of many conditions which are commonly called as comorbidities due to which they cannot made it to survivors list. Also several COVID-19 patients requiring the sophisticated medical attention like ventilators and oxygen support system have any kind of underlying medical condition. Deteriorated immune system is one of the reasons behind slipping into severe symptoms category. Conclusion: It is established that comorbidities are the major influencer in COVID-19 infected patients. More study is needed to further segregate the data on the basis of each comorbidity.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 30 条
[1]  
Afaque SY, 2020, INT J RES PHARM SCI, V11, P1198
[2]  
Agrawal D., 2020, INT J RES PHARM SCI, V35, P376, DOI DOI 10.26452/IJRPS.V11ISPL1.2729
[3]   Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis [J].
Allotey, John ;
Stallings, Elena ;
Bonet, Mercedes ;
Yap, Magnus ;
Chatterjee, Shaunak ;
Kew, Tania ;
Debenham, Luke ;
Llavall, Anna Clave ;
Dixit, Anushka ;
Zhou, Dengyi ;
Balaji, Rishab ;
Lee, Siang Ing ;
Qiu, Xiu ;
Yuan, Mingyang ;
Coomar, Dyuti ;
van Wely, Madelon ;
van Leeuwen, Elizabeth ;
Kostova, Elena ;
Kunst, Heinke ;
Khalil, Asma ;
Tiberi, Simon ;
Brizuela, Vanessa ;
Broutet, Nathalie ;
Kara, Edna ;
Kim, Caron Rahn ;
Thorson, Anna ;
Oladapo, Olufemi T. ;
Mofenson, Lynne ;
Zamora, Javier ;
Thangaratinam, Shakila .
BMJ-BRITISH MEDICAL JOURNAL, 2020, 370
[4]  
[Anonymous], COVID 19 MAP
[5]   Cardiovascular disease and COVID-19 [J].
Bansal, Manish .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (03) :247-250
[6]  
Bawiskar D, 2020, INT J RES PHARM SCI, V11, P385
[7]   Diabetes and COVID-19 [J].
Bouhanick, Beatrice ;
Cracowski, Jean-Luc ;
Faillie, Jean-Luc .
THERAPIE, 2020, 75 (04) :327-333
[8]   The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19 [J].
Callender, Lauren A. ;
Curran, Michelle ;
Bates, Stephanie M. ;
Mairesse, Maelle ;
Weigandt, Julia ;
Betts, Catherine J. .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[9]  
Daniel V, 2020, Clinical Medicine Insights, V1, P27, DOI DOI 10.52845/CMI/2020VLILA5
[10]  
Daniel V, 2020, J.Curr. Diabetes Rep, V1, P12, DOI [10.1080/01652176.2020.1766725, DOI 10.52845/JCDR/2020V1I1A3]